<p>In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Aman Wasan, CEO of ArisGlobal, about the digitisation of drug research and development, including using automation to analyse large datasets to identify new drug development opportunities, with patient safety ever at the forefront of such innovations.</p>

In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Aman Wasan, CEO of ArisGlobal, about the digitisation of drug research and development, including using automation to analyse large datasets to identify new drug development opportunities, with patient safety ever at the forefront of such innovations.

Digitisation of drug R&D: Avoiding new for novelty’s sake

pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our podcasts offer a chance to pose some of these questions to the keenest minds in our industry to look at the big issues and opportunities facing pharma, biotech and healthcare today. With interviews and contributions from a host of industry experts and insiders, the pharmaphorum podcast is a must-listen for those who want insight into the future of health and medicine.

Share Digitisation of drug R&D: Avoiding new for novelty’s sake

Sign up to save your podcasts

Digitisation of drug R&D: Avoiding new for novelty’s sake

Digitisation of drug R&D: Avoiding new for novelty’s sake

More shows like pharmaphorum Podcast

Nature Podcast

The Daily

The Readout Loud

BioCentury This Week

The Mel Robbins Podcast